A Real-World Study on Safety and Efficacy of TAF Treatment in HBV Patients with High Risk of Osteoporosis or Osteopenia in China.
Attention should be paid to osteoporosis risk during lone-term nucleot(s)ide analogue treatment. One minute test of osteoporosis risk could rapidly identify most CHB patients at risk of osteoporosis. Given its convenience, we recommend using this test for early screening in CHB patients prior to initiating antiviral treatment. Our results further demonstrated that an improvement in bone safety after switching to TAF in virologically suppressed CHB patients with osteoporosis.
Authors
- Ming Gong (ORCID: https://orcid.org/0000-0002-3761-5928)
- Zhijian Yu (ORCID: https://orcid.org/0000-0002-5677-2064)
- Hongyan Wang (ORCID: https://orcid.org/0000-0002-7611-427X)
- Wei Jia (ORCID: https://orcid.org/0000-0002-3739-8994)
- Xiang Liu (ORCID: https://orcid.org/0000-0002-1801-3171)
- Chunmei Li (ORCID: https://orcid.org/0000-0003-4240-7565)
- Hui Li (ORCID: https://orcid.org/0000-0003-0142-7500)
- Jiawei Geng (ORCID: https://orcid.org/0000-0002-9122-1532)
- Zi Wang (ORCID: https://orcid.org/0000-0001-5276-2988)
- Yunhua Liu (ORCID: https://orcid.org/0000-0003-2017-3059)
- Ruyi Zhang (ORCID: https://orcid.org/0000-0003-2228-3913)
Publication Details
- Journal
- PubMed
- Published
- 2024-09-01
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77